Short Courses

Sunday, May 3 | 10:00 am - 1:00 pm | Morning Short Courses

Clinical Assessment of Immunogenicity of New Modalities: Focus on Bispecific Antibodies, Gene Therapy and Oligonucleotides
Darshana Jani, MS, Associate Director, Pfizer, Inc.
Ramakrishna Boyanapalli, PhD, Associate Director, Bioanalytical and Biomarker Development, Wave Life Sciences
Magdalena Tary-Lehmann, MD, PhD, CSO, Cellular Technology Limited (CTL); Adjunct Associate Professor of Pathology, Case Western Reserve University (CWRU)
Linzhi Chen, Senior Research Fellow & Bioanalytical Group Leader, Boehringer Ingelheim Pharmaceuticals

Translational Biotherapeutic Development Strategies: Part I, Discovery, Molecular Assessment and Early Stage Development
Zhiqiang An, PhD, Professor, Chemistry; Director, Texas Therapeutics Institute, University of Texas Health Science Center at Houston
Gadi Bornstein, PhD, Senior Director, Biologics Discovery, TESARO, Inc.
Juan Carlos Almagro, PhD, Founder and CEO, GlobalBio, Inc.

Understanding and Modulating Tumor Microenvironment for Immunotherapy
Scott A. Gerber, PhD, Assistant Professor; Co-Director, Center for Tumor Immunology Research, Surgery, Microbiology, Immunology, Radiation Oncology, University of Rochester Medical Center
RJ Tesi, MD, CEO, CMO, INmune Bio

Sunday, May 3 | 2:30 - 5:30 pm | Afternoon Short Courses

In silico and in vitro Immunogenicity Risk Assessment: Overview and Real-Life Examples
Daron Forman, PhD, Principal Scientist, Molecular Discovery Technologies, Bristol-Myers Squibb
Jad Maamary, PhD, Associate Principal Scientist, Predictive and Clinical Immunogenicity, PPDM, Merck & Co., Inc.

Translational Biotherapeutic Development Strategies: Part II, Analytical and Clinical Considerations
Tony Christopeit, PhD, Research Scientist, Roche
An Song, PhD, Senior Vice President, Development Sciences, Immune-Onc Therapeutics, Inc.
Liming Liu, PhD, Senior Vice President, Curon Biopharmaceuticals, China

Introduction to Bispecific Antibodies: Design, Formats and Applications
Nimish Gera, PhD, Director, Research and Development, Mythic Therapeutics

Engineering Better Antibody Therapeutics Using Computational Approaches
Aleksandr Kovaltsuk, MSc (Glas.), DPhil Student, Oxford Protein Informatics Group, Department of Statistics, University of Oxford
Matthew I. J. Raybould, MChem (Oxon.), DPhil Student, Oxford Protein Informatics Group, Department of Statistics, University of Oxford

Tuesday, May 5 | 6:00 - 8:30pm | Dinner Short Courses

Introduction to Biophysical Analysis for Biotherapeutics: Development Applications
Christine P. Chan, PhD, Director, Global Manufacturing Science & Technology, Sanofi

CAR T Cell Therapy from A-Z
Tara Arvedson, PhD, Director, Oncology Research, Amgen

Developability of Bispecific Antibodies: Formats, Assays and Case Studies
Nimish Gera, PhD, Director, Research and Development, Mythic Therapeutics

Emerging Applications for Gene Editing, Base Editing and RNA Editing
Clifford Steer, MD, Professor of Medicine, Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School
Khalid Shah, MS, PhD, Director, Center for Stem Cell Therapies and Imaging, Harvard Medical School; Vice Chair of Research, Brigham and Women’s Hospital
Additional Instructors to be Announced

Thursday, May 7 | 5:45 - 8:15 pm | Dinner Short Courses

Design Strategies and Development of ADCs
Robert Lutz, PhD, Principal Consultant, Crescendo Biopharma Consulting

USP Standards to Support Quality of Potency Measurements
Steven Walfish, MBA, Principal Scientific Liaison, USP
Maura C. Kibbey, PhD, Senior Scientific Fellow, Education & Training, Global Biologics, USP

Introduction to Gene Therapy Products Manufacturing and Analytics
Francis Poulin, PhD, Director, Analytical Development, Sanofi
Claire Davies, PhD, Associate Vice President, Bioanalytics, Sanofi

Assembling an Effective Toolbox of Expression Systems to Support Your Research Efforts
Richard Altman, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific
Additional Instructors to be Announced

* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Traditional Chinese
Simplified Chinese

Update History
Sponsor updated

View By: